Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults
- 5 April 2023
- journal article
- research article
- Published by Springer Nature in Biochemical Genetics
- Vol. 61 (6) , 2276-2292
Abstract
The anti-inflammatory adipokine intelectin-1, which is encoded by the ITLN1 gene, is hypothesized to be linked to the pathogenesis of type 2 diabetes (T2DM) and obesity. The purpose of this study was to examine the effect of the ITLN1 gene polymorphism rs2274907 on obesity and T2DM in Turkish adults. The impact of genotype on lipid profiles and serum intelectin levels in the obese and diabetes groups was also investigated. Randomly selected 2266 adults (mean age, 55.0 ± 11.7 years; 51.2% women) participating in the population-based Turkish adult risk factor study were cross-sectionally analyzed. The genotyping of rs2274907 A > T polymorphism was performed by using the hybridization probe based LightSNiP assay in real-time PCR. T2DM were defined using the criteria of the American Diabetes Association. Obesity was described as Body mass index ≥ 30 kg/m2. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements. According to findings, there was no vital connection between the rs2274907 polymorphism and obesity, T2DM, or serum intelectin-1 level. The TA+AA carriers had significantly higher triglyceride levels (p = 0.007) compared with the TT carriers in both obese and T2DM women when adjusted for relevant covariates. ITLN1 rs2274907 polymorphism is not correlated with the risk of obesity and T2DM and not affect serum ITLN1 levels in Turkish adults. However, this polymorphism appears to be important in regulating triglyceride levels in obese and diabetic women.Keywords
This publication has 26 references indexed in Scilit:
- Annotation of functional variation in personal genomes using RegulomeDBGenome Research, 2012
- Common variants of SLAMF1 and ITLN1 on 1q21 are associated with type 2 diabetes in Indian populationJournal of Human Genetics, 2012
- Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cellsBiochemical and Biophysical Research Communications, 2011
- New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese womenBMC Medical Genetics, 2011
- Changes of Serum Omentin Levels and Relationship between Omentin and Adiponectin Concentrations in Type 2 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2011
- Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver diseaseScandinavian Journal of Gastroenterology, 2010
- Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetesDiabetes Research and Clinical Practice, 2010
- STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statementGenetic Epidemiology, 2009
- Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin actionAmerican Journal of Physiology-Endocrinology and Metabolism, 2006